1. Home
  2. MTX vs OCUL Comparison

MTX vs OCUL Comparison

Compare MTX & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Minerals Technologies Inc.

MTX

Minerals Technologies Inc.

HOLD

Current Price

$72.87

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$8.77

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTX
OCUL
Founded
1968
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
MTX
OCUL
Price
$72.87
$8.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
9
Target Price
$81.33
$23.56
AVG Volume (30 Days)
163.9K
3.4M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
0.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,072,600,000.00
$1,990,000.00
Revenue This Year
$5.66
$7.93
Revenue Next Year
$4.47
$96.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.48
52 Week Low
$49.54
$6.23
52 Week High
$75.30
$16.44

Technical Indicators

Market Signals
Indicator
MTX
OCUL
Relative Strength Index (RSI) 61.44 53.18
Support Level $64.99 $8.36
Resistance Level $75.30 $12.63
Average True Range (ATR) 1.65 0.57
MACD 0.44 0.14
Stochastic Oscillator 85.97 77.32

Price Performance

Historical Comparison
MTX
OCUL

About MTX Minerals Technologies Inc.

Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: